Innoviva, Inc. (INVA) Social Stream
INNOVIVA INC (INVA) Price Targets From Analysts
Use the tables below to see what analysts covering INNOVIVA INC think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
INVA's average price target has moved up $5.17 over the prior 25 months.
INVA reports an average of 9.34% for its upside potential over the past 46 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
INVA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 13 months, INVA's average broker recommendation rating improved by 2.33.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, INNOVIVA INC's number of analysts covering the stock is higher than 35.61% of them.
- To contextualize these metrics, consider that out of all US stocks, INNOVIVA INC's variance in analysts' estimates is lower than -137.88% of them.
- INNOVIVA INC's upside potential (average analyst target price relative to current price) is greater than 139.2% of Pharmaceutical Products stocks.
- In terms of how INNOVIVA INC fares relative to stocks in the mid market cap category, note that its average analyst price target is greater than 143.49% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to INNOVIVA INC are ACAD, PTCT, and SAVA.
View All Top Stocks by Price Target
Make investment decisions regarding INVA using the data that counts. Try POWR Ratings for free.